Category: Top Story
-

Arcturus Therapeutics stock plunges 50% after weak cystic fibrosis trial data
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares sank 50% on Wednesday after the company reported interim Phase 2 results for its cystic fibrosis treatment that failed to deliver significant improvement in lung function. The San Diego-based mRNA drug developer said its inhaled investigational therapy, ARCT-032, was generally safe and well-tolerated in the second cohort of its…
-

Biodesix shares surge 10% on expanded Bio-Rad collaboration
Biodesix (NASDAQ:BDSX) saw its stock jump 10% on Wednesday after announcing an expanded partnership with Bio-Rad Laboratories to advance the development of high-complexity oncology assays using Droplet Digital PCR technology. Under the new agreement, Biodesix will lead development, clinical validation, and regulatory submissions for in vitro diagnostic assays built on Bio-Rad’s ddPCR technology, running on…
-

Healthcare Services Group jumps over 8% as earnings crush forecasts
Healthcare Services Group (NASDAQ:HCSG) saw its shares soar 8.63% in premarket trading on Wednesday after delivering third-quarter results that came in well ahead of expectations, boosted by robust revenue growth and a sizable tax credit. Adjusted earnings for the quarter reached $0.59 per share, handily beating the analyst consensus of $0.21. Revenue totaled $464.3 million,…
-

CME Group tops earnings forecasts but revenue comes in light
CME Group (NASDAQ:CME) reported mixed third-quarter results on Wednesday, with earnings slightly surpassing expectations even as revenue fell short of analyst projections. Adjusted earnings per share came in at $2.68, ahead of the $2.64 consensus estimate. Revenue totaled $1.5 billion, missing forecasts of $1.53 billion. The company’s shares slipped 0.39% in premarket trading following the…
-

VinFast Auto posts 74% jump in Q3 EV deliveries
VinFast Auto (NASDAQ:VFS) reported strong growth in third-quarter vehicle deliveries, underscoring its rapid expansion in both electric car and two-wheeler markets. The Vietnamese automaker delivered 38,195 electric vehicles globally during Q3 2025, a 7% increase from the previous quarter and a 74% jump compared with the same period last year. The company said the VF…
-

Old National Bancorp beats Q3 estimates on revenue strength
Old National Bancorp (NASDAQ:ONB) posted stronger-than-expected third-quarter results on Wednesday, supported by robust revenue growth and improving margins. Adjusted earnings came in at $0.59 per share, ahead of analyst expectations of $0.56. Revenue reached $705.07 million, topping the $696.71 million consensus estimate, thanks to higher net interest income and core deposit expansion. “Old National’s outstanding…
-

Lennox tops earnings forecasts despite softer revenue in Q3
Lennox International Inc. (NYSE:LII) posted better-than-expected third-quarter earnings on Wednesday, even as revenue came in below estimates, reflecting the impact of macroeconomic headwinds and a refrigerant transition year. Adjusted earnings per share for the quarter reached $6.98, slightly ahead of analyst expectations of $6.93. Revenue totaled $1.43 billion, falling short of the $1.5 billion consensus…
-

Avery Dennison shares climb after strong Q3 profit beat
Avery Dennison Corporation (NYSE:AVY) rose 1.63% in premarket trading on Wednesday after the materials science company reported third-quarter earnings that exceeded expectations, highlighting its ability to adapt in what it described as a “dynamic environment.” The company posted adjusted earnings per share of $2.37, topping the analyst consensus of $2.33. Revenue came in at $2.22…
-

Boston Scientific shares rally after strong Q3 earnings beat
Boston Scientific Corporation (NYSE:BSX) surged 4.08% in premarket trading on Wednesday after the medical device maker delivered third-quarter results that comfortably topped Wall Street expectations, fueled by broad-based strength across its business segments. The company reported adjusted earnings per share of $0.75, beating the analyst consensus of $0.71. Revenue rose to $5.07 billion, ahead of…
-

GE Vernova tops revenue forecasts, maintains full-year outlook
GE Vernova Inc. (NYSE:GEV) reported stronger-than-expected third-quarter revenue on Wednesday, supported by solid order growth and a robust backlog, even as earnings came in below analyst forecasts. Shares of the energy transition company rose 1.1% in early trading after the update. Revenue for the quarter reached $9.97 billion, beating the consensus estimate of $9.16 billion…